CG Oncology (CGON) Director Leonard Post Sells 1,000 Shares

What Happened Leonard E. Post, a director of CG Oncology (CGON), exercised stock options and sold 1,000 shares on September 15, 2026. The exercise cost was $0.60 per share (total $600) and the shares were sold in the open market at a weighted average price of $72.98 per share (total proceeds $72,980). The sequence (exercise followed by same‑day sale) reflects a cashless exercise and immediate disposition of the acquired shares.

Key Details

• Transaction date: September 15, 2026.
• Exercise: 1,000 shares exercised at $0.60 per share (total $600).
• Sale: 1,000 shares sold in the open market at a weighted average price of $72.98 (total proceeds $72,980). Reported sale prices ranged $72.54–$73.52.
• Footnotes: Sales were made under a Rule 10b5‑1 trading plan adopted March 5, 2026 (F1). The reported sale price is a weighted average; the filer can provide per‑share sale prices on request (F2). The awards/options were fully vested (F3).
• Shares owned after transaction: Not specified in the filing excerpt.
• Filing timeliness: Report filed September 17, 2026 for a September 15 transaction — appears timely (within the typical two‑business‑day Form 4 window).

Context

• For retail investors: this is a routine insider sale following an option exercise (cashless exercise + immediate sale), not necessarily a view on company fundamentals. Purchases generally carry more signal than routine sales, though the exercise + sale converts equity compensation into cash.
• Net proceeds (approximate): $72,980 proceeds minus $600 exercise cost ≈ $72,380 before taxes and fees.